METROPOLITAN LIFE INSURANCE CO/NY - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$114,641
-33.3%
785
+5.5%
0.01%
-25.0%
Q2 2023$171,864
+4.2%
744
+9.3%
0.01%0.0%
Q1 2023$164,979
-25.4%
681
-10.6%
0.01%
-20.0%
Q4 2022$221,171
+346.6%
7620.0%0.01%
+400.0%
Q3 2022$49,522
-9.2%
7620.0%0.00%0.0%
Q2 2022$54,544
-27.0%
7620.0%0.00%
-33.3%
Q1 2022$74,767
-72.7%
762
-76.4%
0.00%
-25.0%
Q4 2021$273,710
+6.2%
3,2300.0%0.00%0.0%
Q3 2021$257,722
-18.1%
3,2300.0%0.00%0.0%
Q2 2021$314,634
+5.9%
3,230
+27.2%
0.00%0.0%
Q1 2021$297,104
+0.2%
2,540
-4.8%
0.00%0.0%
Q4 2020$296,602
-6.4%
2,6680.0%0.00%
-33.3%
Q3 2020$316,772
+4.8%
2,6680.0%0.01%
+20.0%
Q2 2020$302,151
+69.6%
2,6680.0%0.01%
+25.0%
Q1 2020$178,116
-26.7%
2,6680.0%0.00%0.0%
Q4 2019$243,081
+5.7%
2,6680.0%0.00%0.0%
Q3 2019$230,035
-6.6%
2,668
+13.6%
0.00%0.0%
Q2 2019$246,199
-13.1%
2,349
+3.8%
0.00%
-20.0%
Q1 2019$283,338
+11.1%
2,2620.0%0.01%0.0%
Q4 2018$254,973
-47.4%
2,2620.0%0.01%
-44.4%
Q3 2018$484,362
-99.9%
2,262
+17.3%
0.01%0.0%
Q2 2018$539,522,000
+218.8%
1,929
+33.1%
0.01%
+350.0%
Q1 2018$169,229,000
+127139.8%
1,4490.0%0.00%0.0%
Q4 2017$133,0001,4490.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$11,3428.78%
University of Wisconsin Foundation 40,133$5,861,0236.72%
Paulson & Co. 500,000$73,020,0006.53%
TCG Crossover Management, LLC 179,917$26,275,0793.87%
Avoro Capital Advisors LLC 1,555,000$227,092,2003.54%
Affinity Asset Advisors, LLC 85,000$12,413,4003.49%
Ghost Tree Capital, LLC 57,500$8,397,3002.76%
Lynwood Capital Management Inc. 5,000$730,2001.92%
MPM BioImpact LLC 40,859$5,967,0481.59%
Tri Locum Partners LP 33,761$4,930,4561.58%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders